[1] Curtis C. F,Workshop on Bednet at the International Congress of Tropical Medicine JPM Saint ZOOL. 2, 1993,63-68.
[2] WHO. Reproductive Risk Assessment of Antimalaria Therapy with Artemisinin Compounds" – Reports of an Informal Consultation
Convened by WHO Geneva, 2002 May 29-30.
[3] Breman, J.G., M .S. Alilio and A. Mills, Conquering the intolerable burden of malaria: what's new, w hat's needed: a summary. Am.
J. Trop. Med. Hyg., 71, 2004, 1-15.
[4] Hein, T.T., . An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Vietnam.
Tran. R. Roc. Trop. Med. Hyg., 88(Suppl), 1994, 7-8.
[5] Harinasuta, T. and J. Karbwang. Qinghaosu: A Promising Antimalarial. JAMA SEA; 3.1994
[6] Chanthap, L., R. Tsuyuoka, K. Na-Bangchang, N. Nivanna, D. Suksom, T. Sovannarith and D. Socheat, Investigation of
bioavailability, pharmacokinetics and safety of new pediatric formulations of artesunate and mefloquine Southeast Asian. J. Trop.
Med. Public Health, 36(1), 2005 34-43.
[7] Ittarat W, Udomsangpeth R, Chotivanich RKT, Looareesuwan S, The effects of quinine and artesunate treatment on plasma tumor
necrosis factor levels in malaria infected patients. Southeast Asian Journal of Tropical Medicine and Public Health, 30, 1999 7-10.
[8] Hien, T.T. and White N.Y. Qinghaosu, Lancet 341,1993, 603-608.
[9] Batty KT, Ilett KF, Davis T, Chemical stability of artesunate injection and proposal for its administration by intravenous infusion.
Journal of Pharmacy and Pharmacology, 48, 1996, 22–26.
[10] Price R, van Vugt M, Nosten F, Luxemburger C, Brockman A, Phaipun L, Chonsuphajaissiddi T, White N, Artesunate versus
artemether for the treatment of recrudescent multidrug-resistant falciparum malaria. American Journal of Tropical Medicine and
Hygiene, 59, 1998, 883-888.